Overcoming heterologous protein interdependency to optimize P450-mediated Taxol precursor synthesis in Escherichia coli
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Significance: Metabolic engineering is an economically feasible and sustainable alternative for the production of natural products, pharmaceuticals, nutraceuticals, flavors, and fragrances. Of the model systems used to demonstrate and develop this approach, the anticancer agent Taxol stands out for its structural complexity and therapeutic value. A major challenge for the biosynthesis of Taxol and many other natural products is the involvement of cytochrome P450-mediated oxygenation. P450 enzymes are intransigent to functional heterologous expression, especially in Escherichia coli , leading many laboratories to abandon this organism when engineering P450-containing pathways. Here, through a series of optimizations, we demonstrate E. coli as a viable host for P450-mediated oxidative chemistry, advancing Taxol’s biosynthesis through a fivefold increase in oxygenated terpene titers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-level semi-synthetic production of the potent antimalarial artemisinin
Paddon, C. J., Westfall, P. J., Pitera, D. J., Benjamin, K., Fisher, K., McPhee, D., Leavell, M. D., Tai, A., Main, A., Eng, D., et al. (2013) · Nature · doi:10.1038/nature12051 · Cited by 2,060 · cited 5×
“IPP and DMAPP then are polymerized and cyclized by GGPPS and TxS to form the 20-carbon backbone taxa-4 (5),11 (12)-diene (taxadiene).”
BackgroundInfluentialInterdependence of Cell Growth and Gene Expression: Origins and Consequences
Scott, M., Gunderson, C. W., Mateescu, E. M., Zhang, Z., & Hwa, T. (2010) · Science · doi:10.1126/science.1192588 · Cited by 1,470
Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development
Paddon, C. J., & Keasling, J. D. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3240 · Cited by 675 · cited 2×
“A growing number of examples demonstrate the efficacy of this approach and, for a range of complex molecular families, including alkaloids (3), flavonoids (4), and isoprenoids (5), giving hope for a future in which industrial biotechnology improves both our synthetic approach and access to a vast array of even new-to-…”
BackgroundEngineering Escherichia coli for production of functionalized terpenoids using plant P450s
Chang, M. C. Y., Eachus, R. A., Trieu, W., Ro, D.-K., & Keasling, J. D. (2007) · Nature Chemical Biology · doi:10.1038/nchembio875 · Cited by 364
Cited by
Progress in research on paclitaxel and tumor immunotherapy
Zhu, L., & Chen, L. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0164-y · Cited by 616
Cytochrome P450 Monooxygenases in Biotechnology and Synthetic Biology
Urlacher, V. B., & Girhard, M. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.01.001 · Cited by 355
Metabolic Engineering of Escherichia coli for Natural Product Biosynthesis
Yang, D., Park, S. Y., Park, Y. S., Eun, H., & Lee, S. Y. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.11.007 · Cited by 352
A Compressive Review about Taxol®: History and Future Challenges
Gallego-Jara, J., Lozano-Terol, G., Sola-Martínez, R. A., Cánovas-Díaz, M., & de Diego Puente, T. (2020) · Molecules · doi:10.3390/molecules25245986 · Cited by 344
Engineering cytochrome P450 enzyme systems for biomedical and biotechnological applications
Li, Z., Jiang, Y., Guengerich, F. P., Ma, L., Li, S., & Zhang, W. (2020) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)49939-x · Cited by 260
Metadata
- Authors
- Biggs, B. W., Lim, C. G., Sagliani, K., Shankar, S., Stephanopoulos, G., De Mey, M., & Ajikumar, P. K.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2016-03-07
- Volume
- 113
- Issue
- 12
- Pages
- 3209-3214
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2294225971
- Cited by
- 230
- References
- 4
- FWCI
- 10.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.